Benzinga | Oct 30, 2020 05:07AM EDT

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Raises Price Target to $16

Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and raises the price target from $15 to $16.